Cargando…

Editorial: Antithrombotic Prophylaxis in Patients With Atrial Fibrillation for Stroke Prevention: Evidence From Randomized Clinical Trials, Observational Studies, Methodological Modeling, and More

Detalles Bibliográficos
Autores principales:	Zhang, Junguo, Thabane, Lehana, Li, Ziyi, Li, Guowei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928355/ https://www.ncbi.nlm.nih.gov/pubmed/33681268 http://dx.doi.org/10.3389/fmed.2021.658303

Ejemplares similares

Comparative Effects Between Direct Oral Anticoagulants for Acute Venous Thromboembolism: Indirect Comparison From Randomized Controlled Trials
por: Li, Guowei, et al.
Publicado: (2020)

Editorial: Mechanism and prevention of atrial fibrillation
por: Li, Guowei, et al.
Publicado: (2022)

Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol
por: Li, Guowei, et al.
Publicado: (2015)

The use of antithrombotics in patients presenting with stroke and atrial fibrillation
por: Burgess, Carl, et al.
Publicado: (2007)

Update on Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation
por: Abcede, Hermelinda G., et al.
Publicado: (2010)

Effect of Vitamin D Supplementation on Risk of Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Li, Ziyi, et al.
Publicado: (2021)

Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
por: Lu, Wenbin, et al.
Publicado: (2021)

Antithrombotic prophylaxis of atrial fibrillation in an Italian real-world setting: a retrospective study
por: Ermini, Giuliano, et al.
Publicado: (2017)

Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation
por: Cameron, Chris, et al.
Publicado: (2014)

Association Between GJA1 rs13216675 T>C Polymorphism and Risk of Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Chen, Xuejiao, et al.
Publicado: (2020)

Construction and Analysis of the lncRNA-miRNA-mRNA Network Based on Competing Endogenous RNA in Atrial Fibrillation
por: Ke, Xiangyu, et al.
Publicado: (2022)

Antithrombotic management of patients with acute coronary syndrome and atrial fibrillation undergoing coronary stenting: a prospective, observational, nationwide study
por: De Luca, Leonardo, et al.
Publicado: (2020)

Editorial: Atrial fibrillation in dementia
por: Gotzmann, Michael, et al.
Publicado: (2023)

Antithrombotic alternatives for stroke prevention in atrial fibrillation: critical differences and remaining questions
por: Kalus, James S
Publicado: (2013)

Identification of potential crucial genes in atrial fibrillation: a bioinformatic analysis
por: Zhang, Junguo, et al.
Publicado: (2020)

Antithrombotic Therapy for Chronic Kidney Disease Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease
por: Lee, Kuo-Hua, et al.
Publicado: (2021)

Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease
por: Lee, So-Ryoung, et al.
Publicado: (2022)

Dual antithrombotic therapy and gastroprotection in atrial fibrillation: an observational primary care study
por: Xie, Charis Xuan, et al.
Publicado: (2022)

Comparative Safety and Efficacy of Eight Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Liang, Bo, et al.
Publicado: (2022)

Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update
por: Zhao, Shujuan, et al.
Publicado: (2021)

Do NOACs Improve Antithrombotic Therapy in Secondary Stroke Prevention in Nonvalvular Atrial Fibrillation?
por: Lin, Yi-Pin, et al.
Publicado: (2015)

Evidence-based study on antithrombotic therapy in patients at risk of a stroke with paroxysmal atrial fibrillation
por: CHEN, XINJUN, et al.
Publicado: (2013)

Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation
por: Chu, Gordon, et al.
Publicado: (2020)

The Characteristics, Long-Term Outcomes, Risk Factors, and Antithrombotic Therapy in Chinese Patients With Atrial Fibrillation and Bioprosthetic Valves
por: Ren, Jiameng, et al.
Publicado: (2021)

The sunset of triple antithrombotic therapy for atrial fibrillation patients
por: Capranzano, Piera
Publicado: (2019)

Comorbidities and Antithrombotic Treatment Pattern in Patients With Atrial Fibrillation
por: Bang, Oh Young, et al.
Publicado: (2022)

Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community
por: Joosten, L. P. T., et al.
Publicado: (2022)

Benefits of Emergency Departments’ Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation)
por: Coll-Vinent, Blanca, et al.
Publicado: (2017)

Antithrombotic prophylaxis for symptomatic outpatients with COVID-19: less is consistently more
por: Connors, Jean M, et al.
Publicado: (2022)

A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation
por: LaHaye, Stephen Andrew, et al.
Publicado: (2012)

Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice
por: An, JaeJin, et al.
Publicado: (2015)

Atrial fibrillation in patients with first-ever stroke: Incidence trends and antithrombotic therapy before the event
por: Jung, Yo Han, et al.
Publicado: (2018)

The Impact of Prior Antithrombotic Use on Blood Viscosity in Cardioembolic Stroke with Non-Valvular Atrial Fibrillation
por: Jung, Yo-Han, et al.
Publicado: (2023)

Can We Predict Individual Combined Benefit and Harm of Therapy? Warfarin Therapy for Atrial Fibrillation as a Test Case
por: Li, Guowei, et al.
Publicado: (2016)

Temporal Trends of Antithrombotic Therapy in Patients With Acute Myocardial Infarction and Atrial Fibrillation: Insight From the KAMIR-NIH Registry
por: Lee, Oh-Hyun, et al.
Publicado: (2021)

Efficacy and Safety of Antithrombotic Therapy With Oral Anticoagulants in Real-World Elderly Patients With Acute Coronary Syndrome and Atrial Fibrillation
por: Wu, Yangxun, et al.
Publicado: (2022)

Impact of Antithrombotic Therapy in Atrial Fibrillation on the Presentation of Coronary Artery Disease
por: Chan, Pak Hei, et al.
Publicado: (2015)

Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice
por: Sabir, Ian N, et al.
Publicado: (2013)

Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
por: Wei, Lili, et al.
Publicado: (2020)

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
por: Bor, Wilbert, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_77kel9hfi74htlu9e7b9op0jf2